FDA Review Moves Peptides From Gray Market to Mainstream Fitt Insider FDA Peptide Reclassification 2026: What Researchers Want Potential FDA Peptide Reclassification 2026 What It Means for Patients Beverly Hills Rejuvenation Center The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be